O’Neal to Join the Company’s Board of Advisors and Serve as a Brand Ambassador for Alkaline88® SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- The Alkaline Water Company Inc. (NASDAQ and CSE:WTER) (the...
Market Flashes
Red Moon Proposes Name Change and Renewable Energy Storage Spinout
St. John’s, Newfoundland and Labrador, May 13, 2021 – Red Moon Resources Inc. (the “Company” or “Red Moon” – TSXV:RMK) is pleased to provide the following corporate update: Highlights: Red Moon will...
Gage Growth Corp. Announces Fiscal Year 2020 Results and Provides Business Update
Full Year 2020 revenue increased 1,972% year-over-year to $39.9 millionQ4 2020 revenue increased 615% year-over-year to $10.5 millionEnded 2020 with over $45 million of cash after...
Cardiol Therapeutics Announces First Patient Enrolled in LANCER, a Phase II/III Outcomes Trial in High-risk Patients Hospitalized with COVID-19
Trial designed to investigate the cardioprotective properties of CardiolRx™ in patients hospitalized with COVID-19 who have a prior history of, or risk factors for, cardiovascular disease Oakville,...
Biotech stock to watch! Cardiol Therapeutics announces positive Phase 1 Trial results
Biotech stock Cardiol Therapeutics Inc. (TSX:CRDL | OTCQX:CRTPF | FSE: CT9) is setting the stage for an exciting 2021, as its mission to treat cardiovascular disease picks up pace. In a press...
Relay Medical and Fio Partner with LifeLabs, Canadian Healthcare Leader, to Deploy Fionet Platform for COVID-19 Testing Nationwide
April 14, 2021 – Relay Medical Corp. (“Relay” or the “Company”) (CSE: RELA, OTC: RYMDF, Frankfurt: EIY2) and Fio Corporation (“Fio”) together through their joint venture company, Fionet Rapid...
Cardiol Therapeutics Announces Topline Results from Phase I Single and Multiple Ascending Dose Clinical Trial of CardiolRx™
Results expected to support the Company’s plans to file an IND application withthe FDA for a Phase II international trial in acute myocarditis Oakville, ON – April 12, 2021 – Cardiol Therapeutics...
Gage Cannabis Announces Exclusive Partnership With Blue River™ to Bring Award-Winning Cannabis Extracts to Michigan
Gage is the first operator to manufacture and distribute Blue River™ products in the Midwest. DETROIT, April 8, 2021 – Gage Growth Corp. (“Gage” or the “Company”) (CSE:GAGE), a leading high-quality...
MINDCURE announces additional equity investment in ATMA, the first government approved psychedelic journey centers In Canada; MCUR President and CEO, Kelsey Ramsden named to ATMA Board of Directors
ATMA Was The First Private Sector Service Provider In Canada Conducting Legal Psychedelic-Assisted Therapy For A Palliative Care Patient Under The Approval Of Health Canada's Section 56(1)...
KWESST SIGNS EXCLUSIVE COUNTER-DRONE TECHNOLOGY LICENSE AGREEMENT
Amended license with AerialX Drone Solutions Inc. provides for exclusive rights to U.S. and Canadian militaries. April 6th, 2021 – Ottawa – KWESST Micro Systems Inc. (TSXV: KWE and OTCQB: KWEMF)...
HempFusion’s CBD Products Enter Greater China Through Alibaba Group’s Tmall Global
DENVER, Colo., April 6, 2021 - HempFusion Wellness Inc. (TSX:CBD.U) (US:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness Company offering premium probiotic supplements...
Red White & Bloom Purchases Cultivation Pods for Florida; Immediately Shipping to Ready for Upcoming Deal Closing
30 turn-key grow pods will allow for over 14,000 feet of immediate canopy for cultivation of premium cannabisExisting indoor facility to provide infrastructure for modular pods deployment to support...
MINDCURE Files Provisional Patent Application For iSTRYM, its Proprietary AI Digital Therapeutics (DTx) SaaS Platform, Designed To Enhance Effectiveness Of Psychedelic-Assisted Therapies For Practitioners And Patients
Company Now Is In Two High Growth Rate Global Markets With iSTRYM In The DTx Market, Projected To Reach $56 Billion By 2025 And The Global Psychedelic Market Projected To Reach Over $7.5 Billion By...
Light oil discovery at Touchstone’s Ortoire adds another opportunity
Touchstone Exploration (LON:TXP) on Wednesday said light oil had been discovered on the Ortoire block in onshore Trinidad and Tobago, adding a further level of opportunity for the company. Most...
Cardiol Therapeutics appoints accomplished Chief Medical Officer
On March 30, Cardiol Therapeutics Inc. (TSX: CRDL | OTCQX: CRTPF | FSE: CT9) announced the appointment of Dr Andrew Hamer as Cardiol’s new Chief Medical Officer. He will lead the research and...